Remove the-price-of-innovation-paying-for-a-cure-remains-costly-proposition
article thumbnail

The Price of Innovation: ‘Paying for a Cure’ Remains Costly Proposition

PharmExec

What is being done to smooth the path for pricing and reimbursement? Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting.

119
119